IMOVAX POLIO injection suspension medication leaflet

J07BF03 • inactivated trivalent poliomyelitis vaccine • Antiinfectives for systemic use | Viral vaccines | Poliomyelitis vaccines

The inactivated trivalent polio vaccine (IPV) is used to prevent poliomyelitis, a viral disease caused by three serotypes of the poliovirus, which can lead to paralysis and other severe complications. The vaccine contains inactivated (killed) viruses from all three serotypes, which stimulate the immune system to produce specific antibodies against them, providing long-term protection.

The vaccine is administered intramuscularly or subcutaneously, usually in multiple doses, according to recommended vaccination schedules for children and adults. It is often combined with other vaccines as part of routine immunization programs.

Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.

The inactivated trivalent polio vaccine is an essential measure for the global eradication of poliomyelitis, helping to protect vulnerable populations and prevent the re-emergence of this devastating disease.